Marsanny la Cote, France

Bernard Curtet

This inventor holds 1 USPTO granted patent. Top assignee: Fournier Innovation Et Synergie. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernard Curtet. Retrieved from https://idiyas.com/inventor/bernard-curtet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 126(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernard Curtet: Innovator in Drug Delivery Systems

Introduction

Bernard Curtet, based in Marsanny la Cote, France, is a prominent inventor in the pharmaceutical field. With one patented innovation to his name, he has made significant contributions to improving drug formulations and bioavailability.

Latest Patents

Bernard Curtet holds a patent for a "Novel dosage form of fenofibrate." This innovation involves a unique dosage form of fenofibrate that incorporates a solid surfactant co-micronized with the active ingredient. The invention emphasizes a process for preparing this dosage form, aimed at enhancing its in vivo bioavailability.

Career Highlights

Curtet is affiliated with Fournier Innovation Et Synergie, a company dedicated to advancing pharmaceutical innovations. His work focuses on developing more effective drug delivery systems, aiming to improve patient outcomes through enhanced medication efficacy.

Collaborations

Throughout his career, Bernard has collaborated with notable colleagues, including Eric Teillaud and Philippe Reginault. These partnerships have contributed to the advancement of projects aimed at addressing complex pharmaceutical challenges.

Conclusion

Bernard Curtet exemplifies a dedicated inventor whose work continues to impact the pharmaceutical industry positively. With his innovative approaches and collaborative efforts, he remains a key player in enhancing drug delivery systems and improving therapeutic effectiveness.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…